| Year |
Citation |
Score |
| 2023 |
Gupta P, Herring B, Kumar N, Telange R, Garcia-Buntley SS, Caceres TW, Colantonio S, Williams F, Kurup P, Carter AM, Lin D, Chen H, Rose B, Jaskula-Sztul R, Mukhtar S, et al. Faulty Metabolism: A Potential Instigator of an Aggressive Phenotype in Cdk5-dependent Medullary Thyroid Carcinoma. Biorxiv : the Preprint Server For Biology. PMID 37398342 DOI: 10.1101/2023.06.13.544755 |
0.567 |
|
| 2022 |
Gupta P, Strange K, Telange R, Guo A, Hatch H, Sobh A, Elie J, Carter AM, Totenhagen J, Tan C, Sonawane YA, Neuzil J, Natarajan A, Ovens AJ, Oakhill JS, et al. Genetic impairment of succinate metabolism disrupts bioenergetic sensing in adrenal neuroendocrine cancer. Cell Reports. 40: 111218. PMID 35977518 DOI: 10.1016/j.celrep.2022.111218 |
0.532 |
|
| 2021 |
Carter AM, Kumar N, Herring B, Tan C, Guenter R, Telange R, Howse W, Viol F, McCaw TR, Bickerton HH, Gupta P, Gillardon F, Woltering EA, Dhall D, Totenhagen J, et al. Cdk5 drives formation of heterogeneous pancreatic neuroendocrine tumors. Oncogenesis. 10: 83. PMID 34862365 DOI: 10.1038/s41389-021-00372-5 |
0.548 |
|
| 2020 |
Rai SK, Bril F, Hatch HM, Xu Y, Shelton L, Kalavalapalli S, Click A, Lee D, Beecher C, Kirby A, Kong K, Trevino J, Jha A, Jatav S, Kriti K, ... ... Gupta P, et al. Targeting Pheochromocytoma/Paraganglioma with polyamine inhibitors. Metabolism: Clinical and Experimental. 154297. PMID 32562798 DOI: 10.1016/J.Metabol.2020.154297 |
0.569 |
|
| 2020 |
Rai SK, Bril F, Hatch HM, Xu Y, Shelton L, Kalavalapalli S, Click A, Lee D, Beecher C, Kirby A, Kong K, Trevino J, Jha A, Jatav S, Kriti K, ... ... Gupta P, et al. Targeting Pheochromocytoma/Paraganglioma with polyamine inhibitors. Metabolism: Clinical and Experimental. 154297. PMID 32562798 DOI: 10.1016/J.Metabol.2020.154297 |
0.569 |
|
| Show low-probability matches. |